Tuhura Biosciences YTD Return
The HURA YTD return is 199.87% with dividends reinvested through 06/15/2026. Investors often use YTD return to compare year-to-date performance across securities because current calendar year return information is important for tax planning.
This page shows HURA YTD return, annualized return, start and end dates, and the growth of a hypothetical $10,000 investment with dividends reinvested.
| HURA YTD Return Table | ||||||||||||||||||||||||||||||
HURA YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Use our YTD Return Calculator to
compare HURA YTD return versus benchmarks: YTD Return for S&P YTD Return for Dow YTD Return for Nasdaq 100 YTD Return for Russell 2000 YTD Return for Gold YTD Return for 10 Year Treasury |
| HURA Share Performance |
| HURA YTD Return Chart | |||
Also see: HURA Average Annual Return | |||
| About Tuhura Biosciences Inc |
| Kintara Therapeutics, Inc. is a biopharmaceutical company focused on the development of new solid tumor cancer therapies. Co.'s lead program is REM-001 Therapy for cutaneous metastatic breast cancer (CMBC). REM-001, is a late-stage photodynamic therapy (PDT). PDT is a treatment that uses light sensitive compounds, or photosensitizers, that, when exposed to specific wavelengths of light, act as a catalyst to produce a form of reactive oxygen that induces local tumor cell death. It has a proprietary, late-stage photodynamic therapy platform. REM-001 Therapy consists of the laser light source, the light delivery device, and the REM-001 drug product. The HURA YTD return is shown above.
The YTD Return on the HURA YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether HURA YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the HURA YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| HURA Current Stock Quote |
Quotes delayed 20 minutes  Free HURA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Tuhura Biosciences (HURA) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
HYH YTD Return HYPD YTD Return HYPR YTD Return HZNP YTD Return IART YTD Return IBIO YTD Return IBRX YTD Return ICAD YTD Return ICCC YTD Return ICLR YTD Return More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.
Video: Don't Forget Dividends in YTD Return!